LetsGetChecked is a leading healthcare solutions company that offers a transformative health insights platform. They provide highly scalable and secure proprietary software, with over 10 million tests performed, measuring over 50 biomarkers and detecting almost 250,000 abnormal results. The company has raised $283 million in funding and has offices in New York and Dublin with over 700 employees and growing. They work with over 300+ businesses, closing gaps in care with virtual healthcare solutions, and serve employers, health plans, providers, and the public sector.

Peter Foley

LetsGetChecked

Cezar Health is involved in the medical equipment and healthcare industry, providing products and services related to hospitals, dental units, and consumer health. The company self-described as a participant in various healthcare conferences and has launched its own private label brand in the health sector.

Cezar Health

HeliosX is a health tech company dedicated to improving the quality, accessibility and affordability of healthcare for everyone. Self-described as having created a vertically-integrated healthcare network capable of prescribing and delivering medicines.

HeliosX

Synergy CHC Corp is a consumer health care company. It is in the business of marketing and distributing consumer branded products through various distribution channels primarily in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Synergy generates the majority of its revenue from the sale of Flat Tummy Tea, which is exclusively sold online at www.flattummyco.com. Flat Tummy Tea is a uniquely formulated two-step herbal detox tea that works to naturally help speed metabolism, boost energy and reduce bloating.

Metric
Company Name	LetsGetChecked	Cezar Health	HeliosX	Synergy CHC Corp.
Symbol				SNYR
MSH ID	COM:LETSGETCHECKED	COM:CEZARHEALTH	COM:HELIOSX	COM:SYNERGYCHC
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare	Medical Equipment and Supplies	Health Technology
Country		PS	GB	US
Stage
Employee Count	501			36
Website	letsgetchecked.com	cezarhealth.com	heliosx.com	synergychc.com
LinkedIn			heliosx-group	synergy-chc-corp
Founders

Metric
Market Cap		48.48M
Enterprise Value
Monthly Web Traffic	10.03K	1.76K
Web Traffic Growth	-0.25	0.83
Valuation
Raised Capital		10M

Metric
Revenue				42.78M
Revenue (LTM)
Revenue (NTM)
Gross Profit				32.08M
EBITDA				10.84M
Operating Income				10.81M
Net Income				6.34M
EPS				0.07
Diluted EPS				0.07
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.73
Operating Profit Margin				0.19
EBITDA Margin				0.25
Net Profit Margin				0.06
Return on Equity
Return on Assets				0.07
Return on Capital Employed				9.90

LETS

COM:LETSGETCHECKED

LetsGetChecked

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-0.10
P/B Ratio				-0.17
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				12.31
EV Multiple				59.33

Metric
Days Sales Outstanding				20.83
Days Payables Outstanding				1.05
Days Inventory Outstanding				375.05
Operating Cycle				469.08
Cash Conversion Cycle				469.08
Asset Turnover				1.43

Metric
Operating Cash Flow				421.73K
Free Cash Flow				421.73K
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield				3.28

Metric
Cash & Equivalents				632.53K
Accounts Receivable				1.38M
Inventory				3.73M
Goodwill
Debt to Capitalization				5.59
Debt to Assets				1.10
Current Ratio				0.50
Quick Ratio				0.76

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue
SG&A to Revenue				0.19